Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate-fentanyl versus propofol-fentanyl for pediatric gastrointestinal endoscopy sedation
IRCT20261018071483N1Phase 3Not yet recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial comparing Etomidate + fentanyl with Propofol + fentanyl (2 arms). Primary endpoints: Sedation quality, Cardiorespiratory complications and 3 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
etomidatepropofolfentanyl
Beyond the preview
Go deeper on IRCT20261018071483N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261018071483N1.